Admin

Securing Your Hybrid Workforce with ZTNA

The 10 Must-Have Capabilities of an Effective ZTNA Solution The way we work has undeniably changed. As organizations embrace hybrid work, while also considering return to office, they’re moving growing numbers of mission-critical applications to the cloud so that they can take full advantage of the flexibility, scalability, and efficiencies it offers. But this shift […]

Securing Your Hybrid Workforce with ZTNA Read More »

SSE Leads the Way to SASE

With users and applications anywhere and everywhere, organizations are looking at new, more efficient ways to protect their users and sensitive data. Secure access service edge (SASE) models are drawing plenty of attention, but they require more extensive security and network re-architecting than some organizations are ready for. This is where the security service edge

SSE Leads the Way to SASE Read More »

Small-scale purification of AAV produced with the AAV-MAX system

Production and purification of adeno-associated virus (AAV) at the 50 L scale

In this application note, you’ll discover how you can use the Gibco™ CTS™ AAV‑MAX Helper‑Free AAV Production System Kit to scale up to 50 L production of AAV using the AAV-MAX System, DynaDrive bioreactor, and POROS CaptureSelect resin in an end-to-end workflow. Download now to find out how: With minimal process changes, you can easily

Production and purification of adeno-associated virus (AAV) at the 50 L scale Read More »

Small-scale purification of AAV produced with the AAV-MAX system

Small-scale purification of AAV produced with the AAV-MAX system

The Gibco™ AAV-MAX Helper-Free AAV Production System is an adeno-associated virus (AAV) production system developed for scalable high-titer AAV production. The AAV-MAX system comprises a clonal HEK293F-derived suspension cell line adapted to a chemically defined production medium, a transfection reagent and booster, a production enhancer, and lysis buffer. Here we present two strategies for bench-scale

Small-scale purification of AAV produced with the AAV-MAX system Read More »

Scaling AAV production from 30mL to 1,000 L bioreactors for clinical applications

Scaling AAV production from 30mL to 1,000 L bioreactors for clinical applications

In this webinar, Scalable production of AAV from shake flasks to 1,000 L single use bioreactors using the Gibco™ CTS™ AAV‑MAX Production System, Jon Zmuda from Thermo Fisher Scientific will share several case studies, demonstrating upstream and downstream approaches for consistent and scalable production, purification, and characterization of AAV at scales ranging from shake flasks

Scaling AAV production from 30mL to 1,000 L bioreactors for clinical applications Read More »